Allurion Technologies (ALURD) Depreciation & Amortization (CF) (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Depreciation & Amortization (CF) came in at $171000.0 in Q1 2026, down 15.76% YoY from $203000.0 in Q1 2025, and up 3.64% on a QoQ basis from $165000.0 in Q4 2025.
Allurion Technologies (ALURD) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Depreciation & Amortization (CF) data on file, last reported at $171000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 15.76% year-over-year to $171000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $949000.0 (up 13.79% YoY) and the FY2025 annual result came in at $983000.0, down 1.4% from the prior year.
- Depreciation & Amortization (CF) grew to $171000.0 in Q1 2026, from $165000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $367000.0 in Q1 2024 to a low of $154000.0 in Q2 2023.
- A 5-year average of $223687.5 and a median of $212500.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- The widest YoY moves for Depreciation & Amortization (CF): up 75.63% in 2025, down 44.69% in 2025.
- Tracing ALURD's Depreciation & Amortization (CF) over 5 years: stood at $243000.0 in 2022, then decreased by 22.63% to $188000.0 in 2023, then advanced by 16.49% to $219000.0 in 2024, then fell by 24.66% to $165000.0 in 2025, then increased by 3.64% to $171000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $171000.0 (Q1 2026), $165000.0 (Q4 2025), and $267000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | 171,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 171,000.00 |
| Mar 31, 2026 | 171,000.00 |
| Dec 31, 2025 | 165,000.00 |
| Dec 31, 2025 | 165,000.00 |
| Sep 30, 2025 | 267,000.00 |
| Sep 30, 2025 | 267,000.00 |
| Jun 30, 2025 | 346,000.00 |
| Jun 30, 2025 | 346,000.00 |
| Mar 31, 2025 | 203,000.00 |
| Mar 31, 2025 | 203,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Sep 30, 2024 | 215,000.00 |
| Sep 30, 2024 | 215,000.00 |
| Jun 30, 2024 | 197,000.00 |
| Jun 30, 2024 | 197,000.00 |
| Mar 31, 2024 | 367,000.00 |
| Mar 31, 2024 | 367,000.00 |
| Dec 31, 2023 | 188,000.00 |
| Dec 31, 2023 | 188,000.00 |